Fluoroquinolone antibiotics are used to treat a variety of bacterial infections, including sinusitis, bronchitis, and urinary tract infections. They’re also linked to a variety of health problems and conditions.
In 2016, the U.S. Food and Drug Administration (FDA) reported that fluoroquinolone antibiotics may be linked to disabling and potentially permanent side effects in patients’ tendons, muscles, joints, nerves, and central nervous systems.
In July 2018, the FDA required the manufacturers of fluoroquinolone antibiotics to strengthen warnings concerning the drugs’ links to mental health side effects and blood sugar disturbances. Per the FDA’s findings, the antibiotics are linked to hypoglycemia as well as disorientation, agitation, nervousness, memory impairment, and delirium.
In Dec. 2018, the FDA released another warning concerning fluoroquinolone antibiotics and their link to aortic dissection and ruptures of aortic aneurysm. Due to new findings, the FDA will require that all fluoroquinolone antibiotics include new warnings in their prescribing information and patient medication guides.
At Ferrer Poirot Feller Daniel, we’ve assisted people who were injured by fluoroquinolone antibiotics for many years. The FDA’s latest warning further reinforces the potential dangers that these drugs can pose to patients. If you or someone you love was hurt after taking an antibiotic, contact our drug injury lawyers today for a free consultation.